152 related articles for article (PubMed ID: 19770023)
1. Sex Hormone-Binding Globulin (SHBG), estradiol and breast cancer.
Fortunati N; Catalano MG; Boccuzzi G; Frairia R
Mol Cell Endocrinol; 2010 Mar; 316(1):86-92. PubMed ID: 19770023
[TBL] [Abstract][Full Text] [Related]
2. Sex hormone-binding globulin (SHBG) and estradiol cross-talk in breast cancer cells.
Fortunati N; Catalano MG
Horm Metab Res; 2006 Apr; 38(4):236-40. PubMed ID: 16700004
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of the D327N SHBG protective role on breast cancer development after estrogen exposure.
Costantino L; Catalano MG; Frairia R; Carmazzi CM; Barbero M; Coluccia C; Donadio M; Genta F; Drogo M; Boccuzzi G; Fortunati N
Breast Cancer Res Treat; 2009 Apr; 114(3):449-56. PubMed ID: 18437557
[TBL] [Abstract][Full Text] [Related]
4. Sex hormone-binding globulin antagonizes the anti-apoptotic effect of estradiol in breast cancer cells.
Catalano MG; Frairia R; Boccuzzi G; Fortunati N
Mol Cell Endocrinol; 2005 Jan; 230(1-2):31-7. PubMed ID: 15664449
[TBL] [Abstract][Full Text] [Related]
5. Plasma sex hormone-binding globulin (SHBG) and obesity in breast cancer patients.
Murayama Y
Cancer Detect Prev; 1983; 6(4-5):425-33. PubMed ID: 6686084
[TBL] [Abstract][Full Text] [Related]
6. Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene.
Cui Y; Shu XO; Cai Q; Jin F; Cheng JR; Cai H; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1096-101. PubMed ID: 15894658
[TBL] [Abstract][Full Text] [Related]
7. Sex hormone-binding globulin selectively modulates estradiol-regulated genes in MCF-7 cells.
Catalano MG; Costantino L; Frairia R; Boccuzzi G; Fortunati N
Horm Metab Res; 2007 Apr; 39(4):288-94. PubMed ID: 17447168
[TBL] [Abstract][Full Text] [Related]
8. Sex hormone binding globulin inhibits strongly the uptake of estradiol by human breast carcinoma cells via a deprivative mechanism.
Zeginiadou T; Kortsaris AH; Koliais S; Antonoglou O
Cancer Biochem Biophys; 1998 Oct; 16(3):253-63. PubMed ID: 10072209
[TBL] [Abstract][Full Text] [Related]
9. Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients.
Rose DP; Chlebowski RT; Connolly JM; Jones LA; Wynder EL
Cancer Res; 1992 Oct; 52(19):5386-90. PubMed ID: 1394142
[TBL] [Abstract][Full Text] [Related]
10. Use of confocal microscopy to localize the SHBG interaction with human breast cancer cell lines--a comparison with serum albumin interaction.
Germain P; Egloff M; Kiefer H; Metezeau P; Habrioux G
Cell Mol Biol (Noisy-le-grand); 1997 Jun; 43(4):501-8. PubMed ID: 9220143
[TBL] [Abstract][Full Text] [Related]
11. Intracellular sex hormone-binding globulin (SHBG) in normal and neoplastic breast tissue--an additional marker for hormone dependency?
Meyer S; Brumm C; Stegner HE; Sinnecker GH
Exp Clin Endocrinol; 1994; 102(4):334-40. PubMed ID: 7529185
[TBL] [Abstract][Full Text] [Related]
12. Sex hormone-binding globulin, its membrane receptor, and breast cancer: a new approach to the modulation of estradiol action in neoplastic cells.
Fortunati N; Becchis M; Catalano MG; Comba A; Ferrera P; Raineri M; Berta L; Frairia R
J Steroid Biochem Mol Biol; 1999; 69(1-6):473-9. PubMed ID: 10419027
[TBL] [Abstract][Full Text] [Related]
13. Association of endometrial cancer risk with a functional polymorphism (Asp(327)Asn) in the sex hormone-binding globulin gene.
Kataoka N; Cai Q; Xu WH; Xiang YB; Cai H; Zheng W; Shu XO
Cancer; 2007 Apr; 109(7):1296-302. PubMed ID: 17315164
[TBL] [Abstract][Full Text] [Related]
14. Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women.
Johansson H; Gandini S; Bonanni B; Mariette F; Guerrieri-Gonzaga A; Serrano D; Cassano E; Ramazzotto F; Baglietto L; Sandri MT; Decensi A
Breast Cancer Res Treat; 2008 Mar; 108(1):57-67. PubMed ID: 17468953
[TBL] [Abstract][Full Text] [Related]
15. Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations.
Chubak J; Tworoger SS; Yasui Y; Ulrich CM; Stanczyk FZ; McTiernan A
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1296-301. PubMed ID: 15298949
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of sex-steroid accumulation in the aetiology of human breast carcinoma: the role of intracellular sex hormone binding globulin.
Iqbal MJ; Valyani SH; Roberts JV
Anticancer Res; 1988; 8(3):479-81. PubMed ID: 3389751
[TBL] [Abstract][Full Text] [Related]
17. Phytoestrogen exposure correlation with plasma estradiol in postmenopausal women in European Prospective Investigation of Cancer and Nutrition-Norfolk may involve diet-gene interactions.
Low YL; Taylor JI; Grace PB; Dowsett M; Scollen S; Dunning AM; Mulligan AA; Welch AA; Luben RN; Khaw KT; Day NE; Wareham NJ; Bingham SA
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):213-20. PubMed ID: 15668497
[TBL] [Abstract][Full Text] [Related]
18. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
19. Free estradiol and breast cancer risk in postmenopausal women: comparison of measured and calculated values.
Endogenous Hormones and Breast Cancer Collaborative Group
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1457-61. PubMed ID: 14693737
[TBL] [Abstract][Full Text] [Related]
20. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
